Cromwell Holdings’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.88K Hold
135
– – ﹤0.01% 638
2026
Q2
$7.57K Buy
135
+69
+105% +$3.59K ﹤0.01% 628
2026
Q1
$3.17K Hold
66
– – ﹤0.01% 643
2025
Q4
$2.55K Hold
66
– – ﹤0.01% 660
2025
Q3
$2.33K Hold
66
– – ﹤0.01% 681
2025
Q2
$2.38K Buy
66
+42
+175% +$1.39K ﹤0.01% 661
2025
Q1
$747 Buy
+24
New +$761 ﹤0.01% 698

Other funds holding RPRX

Cromwell Holdings's RPRX Position: Q3 2026 in Review

Cromwell Holdings held its Royalty Pharma (RPRX) position steady in Q3 2026 at 135 shares worth $7.88K. The position accounts for ﹤0.01% of the portfolio, ranked #638.

Cromwell Holdings first reported a position in RPRX in Q1 2025 and has held it in 7 quarters since. 573 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Cromwell Holdings held 135 shares of Royalty Pharma worth $7.88K as of Q3 2026.
  • Cromwell Holdings left its Royalty Pharma share count unchanged in Q3 2026.
  • Royalty Pharma made up ﹤0.01% of Cromwell Holdings's portfolio in Q3 2026, its #638 holding.
  • Cromwell Holdings first reported a position in Royalty Pharma in Q1 2025 and has held it in 7 quarters since.
  • 573 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Cromwell Holdings's 13F filing for Q3 2026, filed 28 Oct 2026.